nature.com search

Loading Filters

Showing 1–37 of 37 results

Loading Filters

Amendments and Corrections | 7 February 2018
Correction: Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT
- L Castagna
- , R Boubdallah
- , S Furst
- , D Coso
- , J El Cheikh
- , C Faucher
- , R Crocchiolo
- , A Granata
- , C Chabannon
- , C Lemarié
- , B Calmels
- , J M Boher
- , M Mohty
- & D Blaise
Bone Marrow Transplantation 53 , 234–234

Rights & permissionsfor article Correction: Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT . Opens in a new window.
Amendments and Corrections | 3 May 2017
Erratum: Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
- L Castagna
- , S Bramanti
- , R Devillier
- , B Sarina
- , R Crocchiolo
- , S Furst
- , J El-Cheikh
- , A Granata
- , C Faucher
- , S Harbi
- , L Morabito
- , J Mariotti
- , S Puvinathan
- , P J Weiller
- , C Chabannon
- , D Mokart
- , C Carlo-Stella
- , R Bouabdallah
- , A Santoro
- & D Blaise
Bone Marrow Transplantation 52 , 797–797

Rights & permissionsfor article Erratum: Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma . Opens in a new window.
Amendments and Corrections | 2 March 2016
Erratum: Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide
- L Castagna
- , S Bramanti
- , S Furst
- , L Giordano
- , B Sarina
- , R Crocchiolo
- , J El-Cheikh
- , A Granata
- , L Morabito
- , E Mauro
- , C Faucher
- , B Mohty
- , S Harbi
- , R Devillier
- , C Chabannon
- , C Carlo-Stella
- , A Santoro
- & D Blaise
Bone Marrow Transplantation 51 , 470–470

Rights & permissionsfor article Erratum: Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide . Opens in a new window.
Amendments and Corrections | 3 June 2015
Erratum: Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
- S Garciaz
- , L Castagna
- , R Bouabdallah
- , S Fürst
- , S Bramanti
- , D Coso
- , R Crocchiolo
- , J El-Cheikh
- , F Broussais
- , C Chabannon
- , A Santoro
- & D Blaise
Bone Marrow Transplantation 50 , 880–880

Rights & permissionsfor article Erratum: Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available . Opens in a new window.
Amendments and Corrections | 3 December 2014
Erratum: Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas
- L Castagna
- , S Bramanti
- , S Furst
- , L Giordano
- , R Crocchiolo
- , B Sarina
- , E Mauro
- , L Morabito
- , R Bouabdallah
- , D Coso
- , M Balzarotti
- , F Broussais
- , J El-Cheikh
- , C C Stella
- , E Brusamolino
- , D Blaise
- & A Santoro
Bone Marrow Transplantation 49 , 1552–1552

Rights & permissionsfor article Erratum: Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas . Opens in a new window.
Amendments and Corrections | 3 September 2014
Erratum: Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors
- L Castagna
- , R Crocchiolo
- , S Furst
- , J El-cheikh
- , B Esterni
- , A Granata
- , A Stoppa
- , R Boubdallah
- , D Coso
- , N Vey
- , A Charbonnier
- , C Lemarie
- , C Faucher
- , C Chabannon
- & D Blaise
Bone Marrow Transplantation 49 , 1248–1248

Rights & permissionsfor article Erratum: Reduced-intensity conditioning regimen with <i>in vivo</i> T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors . Opens in a new window.
Research | 16 January 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
- L Castagna
- , S Bramanti
- , R Devillier
- , B Sarina
- , R Crocchiolo
- , S Furst
- , J El-Cheikh
- , A Granata
- , C Faucher
- , S Harbi
- , L Morabito
- , J Mariotti
- , S Puvinathan
- , P J Weiller
- , C Chabannon
- , D Mokart
- , C Carlo-Stella
- , R Bouabdallah
- , A Santoro
- & D Blaise
Bone Marrow Transplantation 52 , 683–688

Rights & permissionsfor article Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma . Opens in a new window.
15 August 2016
Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis
- P V O'Donnell
- , M Eapen
- , M M Horowitz
- , B R Logan
- , A DiGilio
- , C Brunstein
- , E J Fuchs
- , M E D Flowers
- , R Salit
- , K Raj
- , A Pagliuca
- , K Bradstock
- , A Granata
- , L Castagna
- , S Furst
- & D Blaise
Bone Marrow Transplantation 51 , 1599–1601

Rights & permissionsfor article Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis . Opens in a new window.
18 July 2016
The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
- A Rimondo
- , R Crocchiolo
- , J El-Cheikh
- , S Bramanti
- , A Granata
- , S Furst
- , B Sarina
- , L Morabito
- , R Devillier
- , S Harbi
- , B Mohty
- , R Mineri
- , C Faucher
- , C Chabannon
- , A Santoro
- , D Blaise
- & L Castagna
Bone Marrow Transplantation 52 , 135–137

Rights & permissionsfor article The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide . Opens in a new window.
12 December 2016
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML
- F Legrand
- , A-C Le Floch
- , A Granata
- , S Fürst
- , C Faucher
- , C Lemarie
- , S Harbi
- , S Bramanti
- , B Calmels
- , J El-Cheikh
- , C Chabannon
- , P-J Weiller
- , N Vey
- , L Castagna
- , D Blaise
- & R Devillier
Bone Marrow Transplantation 52 , 620–621

Rights & permissionsfor article Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML . Opens in a new window.
17 October 2016
Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation
- L Castagna
- , B Sarina
- , R Crocchiolo
- , S Bramanti
- , S Furst
- , R Devillier
- , D Coso
- , R Bouabdallah
- , D Mokart
- , L Morabito
- , S Harbi
- , L Giordano
- , A Rimondo
- , P Jean Weiller
- , C Carlo-Stella
- , A Santoro
- , C Chabannon
- & D Blaise
Bone Marrow Transplantation 51 , 1644–1646

Rights & permissionsfor article Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation . Opens in a new window.
21 March 2016
The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide
- R Crocchiolo
- , L Castagna
- , S Furst
- , R Devillier
- , B Sarina
- , S Bramanti
- , J El-Cheikh
- , A Granata
- , S Harbi
- , L Morabito
- , C Faucher
- , A Rimondo
- , D Girardi
- , B Mohty
- , B Calmels
- , C Carlo-Stella
- , C Chabannon
- , R Bouabdallah
- , A Santoro
- , N Vey
- , P J Weiller
- & D Blaise
Bone Marrow Transplantation 51 , 1134–1136

Rights & permissionsfor article The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide . Opens in a new window.
Research | 9 November 2015
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes
- R Devillier
- , S Bramanti
- , S Fürst
- , B Sarina
- , J El-Cheikh
- , R Crocchiolo
- , A Granata
- , C Chabannon
- , L Morabito
- , S Harbi
- , C Faucher
- , A Santoro
- , P-J Weiller
- , N Vey
- , C Carlo-Stella
- , L Castagna
- & D Blaise
Bone Marrow Transplantation 51 , 194–198

Rights & permissionsfor article T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes . Opens in a new window.
Research | 10 June 2013
Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT
- J El-Cheikh
- , G Venton
- , R Crocchiolo
- , S Fürst
- , C Faucher
- , A Granata
- , C Oudin
- , D Coso
- , R Bouabdallah
- , N Vey
- , S Duran
- , E Fougereau
- , P Berger
- , C Chabannon
- & D Blaise
Bone Marrow Transplantation 48 , 1472–1477

Rights & permissionsfor article Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT . Opens in a new window.
Research | 11 June 2013
Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning
- F Malard
- , S Fürst
- , M Loirat
- , P Chevallier
- , J El-Cheikh
- , T Guillaume
- , J Delaunay
- , S Le Gouill
- , P Moreau
- , D Blaise
- & M Mohty
Leukemia 27 , 2113–2117

Rights & permissionsfor article Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning . Opens in a new window.
Research | 2 July 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
- L Tucunduva
- , A Ruggeri
- , G Sanz
- , S Furst
- , G Socié
- , M Michallet
- , W Arcese
- , N Milpied
- , I Yakoub-Agha
- , W Linkesch
- , J Cornelissen
- , L Mannone
- , A P Iori
- , J-M Ribera
- , J Sanz
- , P Montesinos
- , D Purtill
- , M Labopin
- , E Gluckman
- , M Mohty
- & V Rocha
Bone Marrow Transplantation 49 , 887–894

Rights & permissionsfor article Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation . Opens in a new window.
7 July 2014
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors
- L Castagna
- , R Crocchiolo
- , S Furst
- , J El-cheikh
- , B Esterni
- , A Granata
- , A Stoppa
- , R Boubdallah
- , D Coso
- , N Vey
- , A Charbonnier
- , C Lemarie
- , C Faucher
- , C Chabannon
- & D Blaise
Bone Marrow Transplantation 49 , 1246–1247

Rights & permissionsfor article Reduced-intensity conditioning regimen with <i>in vivo</i> T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors . Opens in a new window.
2 March 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
- S Garciaz
- , L Castagna
- , R Bouabdallah
- , S Fürst
- , S Bramanti
- , D Coso
- , R Crocchiolo
- , J El-Cheikh
- , F Broussais
- , C Chabannon
- , A Santoro
- & D Blaise
Bone Marrow Transplantation 50 , 865–867

Rights & permissionsfor article Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available . Opens in a new window.
Research | 15 September 2014
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas
- L Castagna
- , S Bramanti
- , S Furst
- , L Giordano
- , R Crocchiolo
- , B Sarina
- , E Mauro
- , L Morabito
- , R Bouabdallah
- , D Coso
- , M Balzarotti
- , F Broussais
- , J El-Cheikh
- , C C Stella
- , E Brusamolino
- , D Blaise
- & A Santoro
Bone Marrow Transplantation 49 , 1475–1480

Rights & permissionsfor article Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas . Opens in a new window.
23 November 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide
- L Castagna
- , S Bramanti
- , S Furst
- , L Giordano
- , B Sarina
- , R Crocchiolo
- , J El Cheikh
- , A Granata
- , L Morabito
- , E Mauro
- , C Faucher
- , B Mohty
- , S Harbi
- , R Devillier
- , C Chabannon
- , C Carlo-Stella
- , A Santoro
- & D Blaise
Bone Marrow Transplantation 51 , 462–465

Rights & permissionsfor article Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide . Opens in a new window.
Research | 13 January 2014
Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients
- A Xhaard
- , P Rzepecki
- , D Valcarcel
- , S Santarone
- , S Fürst
- , D Serrano
- , G De Angelis
- , W Krüger
- & C Scheid
Bone Marrow Transplantation 49 , 509–512

Rights & permissionsfor article Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients . Opens in a new window.
Research | 6 February 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT
- R Devillier
- , R Crocchiolo
- , L Castagna
- , S Fürst
- , J El Cheikh
- , C Faucher
- , T Prebet
- , A Etienne
- , C Chabannon
- , N Vey
- , B Esterni
- & D Blaise
Bone Marrow Transplantation 47 , 639–645

Rights & permissionsfor article The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT . Opens in a new window.
Research | 31 January 2005
Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)
- A S Michallet
- , F Nicolini
- , S Fürst
- , Q H Le
- , V Dubois
- , S Hayette
- , J P Bourgeot
- , J P Tremisi
- , X Thomas
- , L Gebuhrer
- & M Michallet
Bone Marrow Transplantation 35 , 601–608

Rights & permissionsfor article Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT) . Opens in a new window.
18 February 2008
Rituximab as salvage therapy for refractory chronic GVHD
- M Mohty
- , N Marchetti
- , J El-Cheikh
- , C Faucher
- , S Fürst
- & D Blaise
Bone Marrow Transplantation 41 , 909–911

Rights & permissionsfor article Rituximab as salvage therapy for refractory chronic GVHD . Opens in a new window.
Research | 25 February 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
- H de Lavallade
- , J El-Cheikh
- , C Faucher
- , S Fürst
- , A-M Stoppa
- , D Coso
- , R Bouabdallah
- , C Chabannon
- , J-A Gastaut
- , D Blaise
- & M Mohty
Bone Marrow Transplantation 41 , 953–960

Rights & permissionsfor article Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma . Opens in a new window.
Research | 29 January 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
- J El-Cheikh
- , C Faucher
- , S Fürst
- , S Duran
- , P Berger
- , N Vey
- , A-M Stoppa
- , R Bouabdallah
- , J-A Gastaut
- , P Viens
- , D Blaise
- & M Mohty
Bone Marrow Transplantation 39 , 301–306

Rights & permissionsfor article High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation . Opens in a new window.
22 February 2010
Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning
- T Prébet
- , R Devillier
- , S Fürst
- , N Vey
- & D Blaise
Bone Marrow Transplantation 45 , 1574–1575

Rights & permissionsfor article Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning . Opens in a new window.
Research | 10 December 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT
- L Castagna
- , R Boubdallah
- , S Furst
- , D Coso
- , J El Cheikh
- , C Faucher
- , R Crocchiolo
- , A Granata
- , C Chabannon
- , C Lemarié
- , B Calmels
- , J M Boher
- , M Mohty
- & D Blaise
Bone Marrow Transplantation 48 , 794–798

Rights & permissionsfor article Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT . Opens in a new window.
13 February 2006
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission
- H de Lavallade
- , C Faucher
- , S Fürst
- , J El-Cheikh
- , N Vey
- , D Coso
- , R Bouabdallah
- , A-M Stoppa
- , J-A Gastaut
- , D Blaise
- & M Mohty
Bone Marrow Transplantation 37 , 709–710

Rights & permissionsfor article Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission . Opens in a new window.
26 April 2010
Parvovirus B19 as an etiological agent of acute pleuro-pericarditis
- L Castagna
- , S Furst
- , J El Cheikh
- , C Faucher
- & D Blaise
Bone Marrow Transplantation 46 , 317–318

Rights & permissionsfor article Parvovirus B19 as an etiological agent of acute pleuro-pericarditis . Opens in a new window.
26 June 2008
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison
- M Mohty
- , H de Lavallade
- , J El-Cheikh
- , P Ladaique
- , C Faucher
- , S Fürst
- , N Vey
- , D Coso
- , A-M Stoppa
- , J-A Gastaut
- , C Chabannon
- & D Blaise
Leukemia 23 , 194–196

Rights & permissionsfor article Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison . Opens in a new window.
Research | 25 June 2012
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin’s lymphoma
- R Crocchiolo
- , L Castagna
- , S Fürst
- , J El-Cheikh
- , C Faucher
- , C Oudin
- , A Granata
- , R Bouabdallah
- , D Coso
- , C Chabannon
- , M Balzarotti
- , A Santoro
- & D Blaise
Bone Marrow Transplantation 48 , 249–252

Rights & permissionsfor article Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin’s lymphoma . Opens in a new window.
14 May 2007
Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation
- J-C Meniane
- , J El-Cheikh
- , C Faucher
- , S Fürst
- , R Bouabdallah
- , D Blaise
- & M Mohty
Bone Marrow Transplantation 40 , 175–177

Rights & permissionsfor article Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation . Opens in a new window.
4 August 2008
Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens
- X Cahu
- , M Mohty
- , C Faucher
- , P Chevalier
- , N Vey
- , J El-Cheikh
- , T Guillaume
- , S Furst
- , J Delaunay
- , S Ayari
- , P Moreau
- , J A Gastaut
- , J L Harousseau
- & D Blaise
Bone Marrow Transplantation 42 , 689–691

Rights & permissionsfor article Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens . Opens in a new window.
Research | 4 October 2010
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
- L Castagna
- , S Fürst
- , N Marchetti
- , J El Cheikh
- , C Faucher
- , M Mohty
- , R Bouabdallah
- , N Vey
- , A M Stoppa
- , B Esterni
- & D Blaise
Bone Marrow Transplantation 46 , 1000–1005

Rights & permissionsfor article Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT . Opens in a new window.
Research | 10 December 2012
TLI in refractory chronic GVHD
- R Devillier
- , L Castagna
- , L Gonzague
- , J El-Cheikh
- , S Fürst
- , C Faucher
- , R Michel
- & D Blaise
Bone Marrow Transplantation 48 , 854–858

Rights & permissionsfor article TLI in refractory chronic GVHD . Opens in a new window.
Research | 26 June 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
- S Nguyen
- , A Achour
- , L Souchet
- , S Vigouroux
- , P Chevallier
- , S Furst
- , A Sirvent
- , J-O Bay
- , G Socié
- , P Ceballos
- , A Huynh
- , J Cornillon
- , S Francois
- , F Legrand
- , I Yakoub-Agha
- , G Michel
- , N Maillard
- , G Margueritte
- , S Maury
- , M Uzunov
- , C-E Bulabois
- , M Michallet
- , L Clement
- , C Dauriac
- , K Bilger
- , J Lejeune
- , V Béziat
- , V Rocha
- , B Rio
- , S Chevret
- & V Vieillard
Bone Marrow Transplantation 52 , 1428–1435

Rights & permissionsfor article Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord . Opens in a new window.

Refine your results by…

Filters

Filter By:

Correction: Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

Erratum: Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

Erratum: Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

Erratum: Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available

Erratum: Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

Erratum: Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML

Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation

The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT

Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning

Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)

Rituximab as salvage therapy for refractory chronic GVHD

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation

Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission

Parvovirus B19 as an etiological agent of acute pleuro-pericarditis

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin’s lymphoma

Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation

Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

TLI in refractory chronic GVHD

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters